Literature DB >> 122909

Letter: Mithramycin for hypercalcaemia associated with myeloma and other malignancies.

I E Smith, T J Powles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 122909      PMCID： PMC1672059          DOI： 10.1136/bmj.1.5952.268-d

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Mithramycin treatment of hypercalcemia.

Authors:  C P Perlia; N J Gubisch; J Wolter; D Edelberg; M M Dederick; S G Taylor
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

2.  Neoplasia, hypercalcemia and mithramycin.

Authors:  G Harrington; K B Olson; J Horton; T Cunningham; A Wright
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

3.  Observations on the mechanism of hemorrhagic toxicity in mithramycin (NSC 24559) therapy.

Authors:  R W Monto; R W Talley; M J Caldwell; W C Levin; M M Guest
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.